154 related articles for article (PubMed ID: 19965877)
1. Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primates when administered to simulate emergency contraception.
Hester KE; Harper MJ; Duffy DM
Hum Reprod; 2010 Feb; 25(2):360-7. PubMed ID: 19965877
[TBL] [Abstract][Full Text] [Related]
2. The COX-2 inhibitor meloxicam prevents pregnancy when administered as an emergency contraceptive to nonhuman primates.
McCann NC; Lynch TJ; Kim SO; Duffy DM
Contraception; 2013 Dec; 88(6):744-8. PubMed ID: 24120248
[TBL] [Abstract][Full Text] [Related]
3. Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception.
Jesam C; Salvatierra AM; Schwartz JL; Croxatto HB
Hum Reprod; 2010 Feb; 25(2):368-73. PubMed ID: 19933235
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral administration of a continuous 18 day regimen of meloxicam on ovulation: experience of a randomized controlled trial.
Jesam C; Salvatierra AM; Schwartz JL; Fuentes A; Croxatto HB
Contraception; 2014 Aug; 90(2):168-73. PubMed ID: 24909636
[TBL] [Abstract][Full Text] [Related]
5. Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens.
Brache V; Cochon L; Deniaud M; Croxatto HB
Contraception; 2013 Nov; 88(5):611-8. PubMed ID: 23809278
[TBL] [Abstract][Full Text] [Related]
6. Delay of ovulation by meloxicam in healthy cycling volunteers: A placebo-controlled, double-blind, crossover study.
Bata MS; Al-Ramahi M; Salhab AS; Gharaibeh MN; Schwartz J
J Clin Pharmacol; 2006 Aug; 46(8):925-32. PubMed ID: 16855077
[TBL] [Abstract][Full Text] [Related]
7. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
8. Feasibility study of Nestorone-ethinylestradiol vaginal contraceptive ring for emergency contraception.
Croxatto HB; Brache V; Massai R; Alvarez F; Forcelledo ML; Pavez M; Cochon L; Salvatierra AM; Faundes A
Contraception; 2006 Jan; 73(1):46-52. PubMed ID: 16371294
[TBL] [Abstract][Full Text] [Related]
9. Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys.
Duffy DM; Stouffer RL
Hum Reprod; 2002 Nov; 17(11):2825-31. PubMed ID: 12407033
[TBL] [Abstract][Full Text] [Related]
10. Does meloxicam increase the incidence of anovulation induced by single administration of levonorgestrel in emergency contraception? A pilot study.
Massai MR; Forcelledo ML; Brache V; Tejada AS; Salvatierra AM; Reyes MV; Alvarez F; Faúndes A; Croxatto HB
Hum Reprod; 2007 Feb; 22(2):434-9. PubMed ID: 16980507
[TBL] [Abstract][Full Text] [Related]
11. Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function.
Tirelli A; Cagnacci A; Volpe A
Contraception; 2008 May; 77(5):328-32. PubMed ID: 18402847
[TBL] [Abstract][Full Text] [Related]
12. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
[TBL] [Abstract][Full Text] [Related]
13. Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway.
Duffy DM
Hum Reprod Update; 2015; 21(5):652-70. PubMed ID: 26025453
[TBL] [Abstract][Full Text] [Related]
14. A prostaglandin E2 receptor antagonist prevents pregnancies during a preclinical contraceptive trial with female macaques.
Peluffo MC; Stanley J; Braeuer N; Rotgeri A; Fritzemeier KH; Fuhrmann U; Buchmann B; Adevai T; Murphy MJ; Zelinski MB; Lindenthal B; Hennebold JD; Stouffer RL
Hum Reprod; 2014 Jul; 29(7):1400-12. PubMed ID: 24781425
[TBL] [Abstract][Full Text] [Related]
15. Impact of the prostaglandin synthase-2 inhibitor celecoxib on ovulation and luteal events in women.
Edelman AB; Jensen JT; Doom C; Hennebold JD
Contraception; 2013 Mar; 87(3):352-7. PubMed ID: 22902348
[TBL] [Abstract][Full Text] [Related]
16. Further investigation on meloxicam contraceptivity in female rabbits: luteinizing unruptured follicles, a microscopic evidence.
Salhab AS; Amro BI; Shomaf MS
Contraception; 2003 Jun; 67(6):485-9. PubMed ID: 12814819
[TBL] [Abstract][Full Text] [Related]
17. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model.
Quintana R; Kopcow L; Marconi G; Young E; Yovanovich C; Paz DA
Fertil Steril; 2008 Oct; 90(4 Suppl):1511-6. PubMed ID: 18166186
[TBL] [Abstract][Full Text] [Related]
20. "Sunday start" multiphasic oral contraception: ovulation prevention and delayed follicular atresia in primates.
Danforth DR; Hodgen GD
Contraception; 1989 Mar; 39(3):321-30. PubMed ID: 2496952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
